CD80 (B7-1) and CD86 (B7-2): potential targets for immunotherapy?
Department of Pathophysiology, Catholic University of Leuven, Belgium.
S W
SW
van Gool
S
S
Barcy
S
S
Devos
P
P
Vandenberghe
J L
JL
Ceuppens
K
K
Thielemans
M
M
de Boer
D000069594:Abatacept; D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D015703:Antigens, CD / Q000378:metabolism*; D000943:Antigens, Differentiation / Q000378:metabolism; D015551:Autoimmunity; D018122:B7-1 Antigen / Q000378:metabolism*; D051940:B7-2 Antigen; D018106:CD28 Antigens / Q000378:metabolism; D060908:CTLA-4 Antigen; D017635:Clonal Anergy; D016572:Cyclosporine / Q000494:pharmacology; D006084:Graft Rejection / Q000276:immunology; D006801:Humans; D018796:Immunoconjugates; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007167:Immunotherapy / Q000379:methods*; D066298:In Vitro Techniques; D007239:Infections / Q000276:immunology; D008213:Lymphocyte Activation; D008562:Membrane Glycoproteins / Q000378:metabolism*; D009369:Neoplasms / Q000628:therapy; D015398:Signal Transduction / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology
D015703:Antigens, CD; D000943:Antigens, Differentiation; D018122:B7-1 Antigen; D051940:B7-2 Antigen; D018106:CD28 Antigens; C497964:CD86 protein, human; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D008562:Membrane Glycoproteins; D000069594:Abatacept; D016572:Cyclosporine